Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis in Vitro1

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130

The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis

Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S.-I., Sameshima, M., Hase, A., Seto, Y., & Nagata, S. (1991) · Cell · doi:10.1016/0092-8674(91)90614-5 · Cited by 2,736

The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death

Smith, C. A., Farrah, T., & Goodwin, R. G. (1994) · Cell · doi:10.1016/0092-8674(94)90372-7 · Cited by 1,909

The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene

Yoshida, H., Hayashi, S.-I., Kunisada, T., Ogawa, M., Nishikawa, S., Okamura, H., Sudo, T., Shultz, L. D., & Nishikawa, S.-I. (1990) · Nature · doi:10.1038/345442a0 · Cited by 1,789

Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6

Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B. F., Broxmeyer, H. E., & Manolagas, S. C. (1992) · Science · doi:10.1126/science.1621100 · Cited by 1,440

SRα Promoter: an Efficient and Versatile Mammalian cDNA Expression System Composed of the Simian Virus 40 Early Promoter and the R-U5 Segment of Human T-Cell Leukemia Virus Type 1 Long Terminal Repeat

Takebe, Y., Seiki, M., Fujisawa, J., Hoy, P., Yokota, K., Arai, K., Yoshida, M., & Arai, N. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.1.466-472.1988 · Cited by 1,330

A novel domain within the 55 kd TNF receptor signals cell death

Tartaglia, L. A., Ayres, T. M., Wong, G. H., & Goeddel, D. V. (1993) · Cell · doi:10.1016/0092-8674(93)90464-2 · Cited by 1,290

Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas Molecule

Cheng, J., Zhou, T., Liu, C., Shapiro, J. P., Brauer, M. J., Kiefer, M. C., Barr, P. J., & Mountz, J. D. (1994) · Science · doi:10.1126/science.7510905 · Cited by 1,108

Modulation of Osteoclast Differentiation

Suda, T., Takahashi, N., & Martin, T. J. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-66 · Cited by 1,004

OSTEOBLASTIC CELLS ARE INVOLVED IN OSTEOCLAST FORMATION

Takahashi, N., Akatsu, T., Udagawa, N., Sasaki, T., Yamaguchi, A., Moseley, J. M., Martin, T. J., & Suda, T. (1988) · Endocrinology · doi:10.1210/endo-123-5-2600 · Cited by 934

Roles of osteoclasts in pathological conditions

Kitazawa, S., Haraguchi, R., & Kitazawa, R. (2024) · Pathology International · doi:10.1111/pin.13500 · Cited by 15

Effects of Creatine Monohydrate Supplementation on Muscle, Bone and Brain- Hope or Hype for Older Adults?

Candow, D. G., & Moriarty, T. A. (2024) · Current Osteoporosis Reports · doi:10.1007/s11914-024-00895-x · Cited by 20

Nanogel-crosslinked nanoparticles increase the inhibitory effects of W9 synthetic peptide on bone loss in a murine bone resorption model

Aoki, K., Sato, T., Alles, N., Khan, M., Nagano, K., Takahashi, M., Tamura, Y., Shimoda, A., Akiyoshi, K., & Ohya, K. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s61566 · Cited by 15

Role of Serum Osteoprotegerin as a Diagnostic Indicator of Primary Osteoporosis in Perimenopausal and Postmenopausal Women: An Indian Perspective

Pandey, A., Ya, K., Kushwaha, S. S., Mohammed, F., & Verma, A. (2018) · Malaysian Orthopaedic Journal · doi:10.5704/moj.1803.006 · Cited by 15

Osteoprotegerin (OPG) pathways in bone diseases and its application in therapeutic perspectives

Jayash, S. N., Al-Namnam, N. M., & Shaghayegh, G. (2020) · Biointerface Research in Applied Chemistry · doi:10.33263/briac102.193200 · Cited by 15

DMSO regulates osteoclast development in vitro

Lemieux, J. M., Wu, G. D., Morgan, J. A., & Kacena, M. A. (2011) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-011-9385-8 · Cited by 15

Bone Continuum of Cancer

Lipton, A. (2010) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3181deb9e5 · Cited by 15

Physiologie du tissu osseux

Thomas, T., Martin, A., & Lafage‐Proust, M. (2008) · EMC - Appareil locomoteur · doi:10.1016/s0246-0521(08)40315-7 · Cited by 24

Sargachromanol G regulates the expression of osteoclastogenic factors in human osteoblast-like MG-63 cells

Yoon, W., Heo, S., Han, S.-C., Lee, H. J., Kang, G.-J., Yang, E.-J., Park, S.-S., Kang, H.-K., & Yoo, E.-S. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.06.022 · Cited by 15

A novel oxazine ring closure reaction affording (Z)-((E)-2-styrylbenzo[b]furo[3,2-d][1,3]oxazin-4-ylideno)acetaldehydes and their anti-osteoclastic bone resorption activity

Ando, Y., Ando, K., Yamaguchi, M., Kunitomo, J., Koida, M., Fukuyama, R., Nakamuta, H., Yamashita, M., Ohta, S., & Ohishi, Y. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.08.064 · Cited by 15

Relationships between serum osteoprotegerin, matrix metalloproteinase-2 levels and bone metabolism in postmenopausal women

Dai, Y., & Shen, L. (2007) · Chinese Medical Journal · doi:10.1097/00029330-200711020-00015 · Cited by 15

Bone and Cartilage – its Structure and Physical Properties

Wojnar, R. (2010) · doi:10.1002/9783527632732.ch1 · Cited by 15

A Novel Small Molecule Which Increases Osteoprotegerin Expression and Protects Against Ovariectomy-Related Bone Loss in Rats

Han, X., Gong, S., Ni, L., Wang, X., Liu, P., Xu, Y., He, X., Jiang, W., & Si, S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00103 · Cited by 15

Does one dose of creatine supplementation fit all?

Candow, D. G., Ostojić, S. M., Forbes, S. C., & António, J. (2024) · Advanced Exercise and Health Science · doi:10.1016/j.aehs.2024.05.002 · Cited by 20

Porphyromonas gingivalis induces RANKL in bone marrow stromal cells: Involvement of the p38 MAPK

Reddi, D., Brown, S. J., & Belibasakis, G. N. (2011) · Microbial Pathogenesis · doi:10.1016/j.micpath.2011.09.001 · Cited by 14

Maternal circulating osteoprotegerin and soluble RANKL in pre-eclamptic women

Vitoratos, N., Lambrinoudaki, I. V., Rizos, D., Armeni, E., Alexandrou, A. P., & Creatsas, G. K. (2010) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2010.10.009 · Cited by 14

Effect of Kiwifruit on Bone Resorption in Ovariectomized Mice

Katsumata, S.-I., Wolber, F. M., Tadaishi, M., Tousen, Y., Ishimi, Y., & Kruger, M. C. (2015) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.61.332 · Cited by 14

Collagen type I signaling reduces the expression and the function of human receptor activator of nuclear factor ‐κB ligand (RANKL) in T lymphocytes

Gendron, S., Couture, J., & Aoudjit, F. (2005) · European Journal of Immunology · doi:10.1002/eji.200535065 · Cited by 14

Effects of osteoprotegerin administration on osteoclast differentiation and trabecular bone structure in osteoprotegerin-deficient mice

Yamazaki, H., & Sasaki, T. (2005) · Microscopy · doi:10.1093/jmicro/dfi066 · Cited by 14

Effects of Aging on Osteosynthesis at Bone–Implant Interfaces

Pius, A. K., Toya, M., Gao, Q., Lee, M. L., Ergul, Y. S., Chow, S. K., & Goodman, S. B. (2023) · Biomolecules · doi:10.3390/biom14010052 · Cited by 13

Dental root resorption etiology, diagnosis and treatment

Im, R., Snegirev, M. V., & Markheev, C. I. (2019) · Stomatology · doi:10.17116/stomat201998031109 · Cited by 13

Cucumber seed polypeptides regulate RANKL-induced osteoclastogenesis through OPG/RANKL/RANK and NF-κB

Yu, T., Liu, X., Jiang, M., Li, Y., Su, H., & Niu, B. (2023) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-023-00834-7 · Cited by 13

Bone microenvironment-targeted manipulations for the treatment of osteoblastic metastasis in castration-resistant prostate cancer

Msaouel, P., Nandikolla, G., Pneumaticos, S. G., & Koutsilieris, M. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.824422 · Cited by 13

Murine osteoblasts respond to LPS and IFN-γ similarly to macrophages

Maruyama, K., Sano, G., & Matsuo, K. (2006) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-006-0708-x · Cited by 13

Basic Fibroblast Growth Factor Inhibits Osteoclast Formation Induced by 1α,25-Dihydroxyvitamin D3 through Suppressing the Production of Osteoclast Differentiation Factor

Nakagawa, N., Yasuda, H., Yano, K., Mochizuki, S.-I., Kobayashi, N., Fujimoto, H., Yamaguchi, K., Shima, N., Morinaga, T., & Higashio, K. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1621 · Cited by 13

The role of osteoprotegerin (OPG) receptor activator for nuclear factor kappaB ligand (RANKL) in cardiovascular pathology – a review

Malliga, D.-E., Wagner, D., & Fahrleitner‐Pammer, A. (2011) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-011-0022-7 · Cited by 14

New developments in calcium and vitamin D metabolism

Langman, C. B. (2000) · Current Opinion in Pediatrics · doi:10.1097/00008480-200004000-00009 · Cited by 13

Osteoprotegerin reduces the loss of periarticular bone mass in primary and secondary spongiosa but does not influence inflammation in rat antigen-induced arthritis.

Neumann, T., Oelzner, P., Petrow, P. K., Thoss, K., Hein, G., Stein, G., & Bräuer, R. (2006) · Inflammation Research · doi:10.1007/s00011-005-0005-5 · Cited by 12

The homeostasis and therapeutic applications of innate and adaptive immune cells in periodontitis

Li, J., Mehrabanian, M., Mivehchi, H., Banakar, M., & Etajuri, E. A. (2022) · Oral Diseases · doi:10.1111/odi.14360 · Cited by 15

Effects of RANKL Knockdown by Virus-like Particle-Mediated RNAi in a Rat Model of Osteoporosis

Hoffmann, D. B., Gruber, J., Böker, K. O., Deppe, D., Sehmisch, S., Schilling, A. F., Lemus-Diaz, N., Komrakova, M., & Schneider, S. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.06.001 · Cited by 12

Human circulating monocytes can express receptor activator of nuclear factor‐κB ligand and differentiate into functional osteoclasts without exogenous stimulation

Seta, N., Okazaki, Y., & Kuwana, M. (2008) · Immunology and Cell Biology · doi:10.1038/icb.2008.4 · Cited by 12

Loss of inhibition over master pathways of bone mass regulation results in osteosclerotic bone metastases in prostate cancer

Rentsch, C. A., Cecchini, M. G., & Thalmann, G. N. (2009) · Swiss Medical Weekly · doi:10.4414/smw.2009.12284 · Cited by 12

Genetic Testing in Periodontitis: A Narrative Review on Current Applications, Limitations, and Future Perspectives

Modafferi, C., Grippaudo, C., Corvaglia, A., Cristi, V., Amato, M., Rigotti, P., Polizzi, A., & Isola, G. (2025) · Genes · doi:10.3390/genes16111308 · Cited by 11

Downregulation of RANKL and RANKL/osteoprotegerin ratio in human periodontal ligament cells during their osteogenic differentiation

Tang, X., Han, J., Meng, H., Zhao, Y., Wang, H., Liu, J., Lin, L., Zhang, D., Li, C., & Ma, C. (2015) · Journal of Periodontal Research · doi:10.1111/jre.12291 · Cited by 11

The many roles of RANKL-RANK signaling in bone, breast and cancer

Schramek, D., & Penninger, J. M. (2011) · IBMS BoneKEy · doi:10.1138/20110512 · Cited by 11

Osteoprotegerin (OPG) and Related Proteins (RANK, RANKL and TRAIL) in Thyroid Disease

Sood, S. K., Balasubramanian, S. P., Higham, S. E., Fernando, M. S., & Harrison, B. J. (2011) · World Journal of Surgery · doi:10.1007/s00268-011-1185-5 · Cited by 11

Genetic factors influencing the risk of multiple myeloma bone disease

Johnson, D. C., Weinhold, N., Mitchell, J. S., Chen, B., Stephens, O., Försti, A., Nickel, J., Kaiser, M., Gregory, W. M., Cairns, D. A., et al. (2015) · Leukemia · doi:10.1038/leu.2015.342 · Cited by 11

Distribution of RANK and RANK Ligand in Normal Human Tissues as Determined by an Optimized Immunohistochemical Method

Taylor, C. R., Branstetter, D. G., Manna, E. A., Dougall, W. C., Bussiere, J. L., & Johnson, C. W. (2017) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000503 · Cited by 11

Phelligridin D-loaded oral nanotube titanium implant enhances osseointegration and prevents osteolysis in rat mandible

Kim, J.-E., Takanche, J. S., Kim, J., Lee, M., Jeon, J., Park, I., & Yi, H. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1458033 · Cited by 11

Crystal Structure of RANK Ligand Involved in Bone Metabolism

Ito, S., & Hata, T. (2004) · Vitamins and hormones · doi:10.1016/s0083-6729(04)67002-6 · Cited by 11

Bilateral Giant Cavernous Carotid Artery Aneurysms in a Child With Juvenile Paget's Disease

Rehman, T., Ali, R., Taylor, C. L., & Yonas, H. (2010) · World Neurosurgery · doi:10.1016/j.wneu.2010.01.022 · Cited by 11

Infliximab acts directly on human osteoclast precursors and enhances osteoclast formation induced by receptor activator of nuclear factor κB ligand in vitro

Takita, C., Fujikawa, Y., Itonaga, I., Taira, H., Kawashima, M., & Torisu, T. (2005) · Modern Rheumatology · doi:10.1007/s10165-004-0373-7 · Cited by 11

Elevated Suppressor of Cytokine Signaling-1 (SOCS-1): A Mechanism for Dysregulated Osteoclastogenesis in HIV Transgenic Rats

Lafferty, M., Fantry, L., Bryant, J., Jones, O. D., Hammoud, D., Weitzmann, M., Lewis, G., Garzino-Demo, A., & Reid, W. (2014) · Pathogens and Disease · doi:10.1111/2049-632x.12117 · Cited by 12

Renal and Skeletal Actions of Parathyroid Hormone (PTH) and PTH-Related Protein

Bringhurst, F. R., & Strewler, G. J. (2002) · Elsevier eBooks · doi:10.1016/b978-012098652-1.50130-x · Cited by 11

Cytotoxic Signal Transmission Pathways via TNF Family Receptors

Петрович, Б. И., Moshnikova, A., & Prusakova, O. V. (2002) · Biochemistry (Moscow) · doi:10.1023/a:1014884400144 · Cited by 11

Single-cell multi-omics identify novel regulators required for osteoclastogenesis during aging

Li, H., Xu, W., Tan, J.-C., Hong, Y.-M., He, J., Zhao, B.-P., Zhou, J., Zheng, Y.-M., Lei, M., Zheng, X., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110734 · Cited by 12

TNF Conference 2009: Beyond Bones – RANKL/RANK in the Immune System

Leibbrandt, A., & Penninger, J. M. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6612-4_2 · Cited by 10

Pathophysiology and Pharmacological Targeting of Tumor-Induced Bone Disease: Current Status and Emerging Therapeutic Interventions

Labropoulou, V., Theocharis, A. D., Symeonidis, A. S., Skandalis, S. S., Karamanos, N. K., & Kalofonos, H. P. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795471275 · Cited by 10

Soluble receptors for advanced glycation end products and receptor activator of NF-κB ligand serum levels as markers of premature labor

Rzepka, R., Dołęgowska, B., Sałata, D., Rajewska, A., Budkowska, M., Domański, L., Kwiatkowski, S., Mikołajek-Bedner, W., & Torbè, A. (2015) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-015-0559-3 · Cited by 10

Beyond bone remodeling–emerging functions of osteoprotegerin in host defense and microbial infection

Kobayashi‐Sakamoto, M., Tamai, R., & Kiyoura, Y. (2015) · Integrative Molecular Medicine · doi:10.15761/imm.1000173 · Cited by 9

Predictive Value of Osteoprotegerin and Neutrophil Gelatinase-associated Lipocalin on Multiple Organ Failure in Multiple Trauma

PETERS, H., Macke, C., Mommsen, P., Zeckey, C., Clausen, J., Krettek, C., Neunaber, C., & Winkelmann, M. (2019) · In Vivo · doi:10.21873/invivo.11639 · Cited by 10

Osteoprotegerin gene polymorphisms and otosclerosis: an additional genetic association study, multilocus interaction and meta-analysis

Bouzid, A., Tekari, A., Jbeli, F., Chakroun, A., Hansdah, K., Souissi, A., Singh, N., Mosrati, M. A., Achour, I., Ghorbel, A., et al. (2020) · BMC Medical Genetics · doi:10.1186/s12881-020-01036-8 · Cited by 10

Minocycline to be used a potential anti-bone resorption agents due to the suppression of osteoclastic bone resorption

Udagawa, N., Koide, M., Nakamura, M., & Takahashi, N. (2013) · Journal of Oral Biosciences · doi:10.1016/j.job.2013.01.001 · Cited by 10

Manipulation of receptor oligomerization as a strategy to inhibit signaling by TNF superfamily members

Warren, J. T., Nelson, C. A., Decker, C. E., Zou, W., Fremont, D. H., & Teitelbaum, S. L. (2014) · Science Signaling · doi:10.1126/scisignal.2004948 · Cited by 10

Activation of cannabinoid receptor CB2 regulates LPS-induced pro-inflammatory cytokine production and osteoclastogenic gene expression in human periodontal ligament cells

Qian, H., Yi, J., Zhou, J., Zhao, Y., Li, Y., Jin, Z., & Ding, Y. (2013) · Open Journal of Stomatology · doi:10.4236/ojst.2013.31009 · Cited by 10

Denosumab in Breast Cancer

Lipton, A. (2010) · Current Oncology Reports · doi:10.1007/s11912-010-0135-y · Cited by 10

Proteomic study of different culture medium serum volume fractions on RANKL-dependent RAW264.7 cells differentiating into osteoclasts

Xiong, Q., Zhang, L., Xin, L., Gao, Y., Ye, P., Tang, P., & Ge, W. (2015) · Proteome Science · doi:10.1186/s12953-015-0073-6 · Cited by 10

Combined effect of fluoride and arsenate on gene expression of osteoclast differentiation factor and osteoprotegerin.

Jia, L., & Jin, T. Y. (2006) · PubMed · Cited by 10

Effects of constrained dynamic loading, CKIP‑1 gene knockout and combination stimulations on bone loss caused by mechanical unloading

Han, B., Wei, S., Zhang, X., Li, H., Li, Y., Li, R., Li, K., & Zhang, X. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9222 · Cited by 10

Studies of human osteoblasts in vitro: Estrogen actions and interactions with other hormones at different stages of differentiation

Rao, L. G., & Murray, T. M. (2000) · Drug Development Research · doi:10.1002/(sici)1098-2299(200003)49:3 · Cited by 10

The Role of RANKL and Involvement of Cementum in Orthodontic Root Resorption

Yamaguchi, M., & Mishima, H. (2021) · Applied Sciences · doi:10.3390/app11167244 · Cited by 9

Biomaterials and Bone Remodeling: The Physiologic Process Required for Biologization of Bone Substitutes

Amling, M., Schilling, A. F., Pogoda, P., Priemel, M., & Rueger, J. M. (2006) · European Journal of Trauma · doi:10.1007/s00068-006-6049-6 · Cited by 9

Osteoprotegerin promotes islet β cell proliferation in intrauterine growth retardation rats through the PI3K/AKT/FoxO1 pathway.

Tang, S., Xin, Y., Yang, M. C., Zhang, D., & Xu, C. (2019) · Europe PMC (PubMed Central) · Cited by 8

Regulation of bone lysis in inflammatory diseases

Haynes, D. R., & Crotti, T. N. (2003) · Inflammopharmacology · doi:10.1163/156856003322699500 · Cited by 9

The Association of Serum Osteoprotegerin and Osteoporosis in Postmenopausal Hemodialysis Patients: A Pilot Study

Wu, W.-T., Lee, R.-P., Wang, C., Fang, T., Lin, N.-T., Chen, I., & Hsu, B. (2010) · Journal of Women s Health · doi:10.1089/jwh.2009.1577 · Cited by 9

Serum osteoprotegerin and soluble receptor activator of nuclear factor κB ligand levels in patients with a history of differentiated thyroid carcinoma: a case-controlled cohort study

Giusti, M., Cecoli, F., Fazzuoli, L., Franchis, V. D., Ceresola, E., Ferone, D., Mussap, M., & Minuto, F. M. (2007) · Metabolism · doi:10.1016/j.metabol.2007.01.004 · Cited by 9

Effects of celecoxib on the expression of osteoprotegerin, energy metabolism and cell viability in cultured human osteoblastic cells.

Kolar, P., Lach, S., Gaber, T., Maschmeyer, P., Dziurla, R., Tripmacher, R., Krocker, D., Matziolis, G., Perka, C., Gr, B., et al. (2009) · PubMed · Cited by 9

Origins of Osteoclasts

Galson, D. L., & Roodman, G. D. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375670-1.10002-0 · Cited by 9

Basic Aspects of Osteoblast Function

Vrahnas, C., & Sims, N. A. (2020) · Contemporary Endocrinology · doi:10.1007/978-3-319-69287-6_1 · Cited by 10

Expression of osteoprotegerin in synovial tissue and degradation of articular cartilage: Comparison with arthroscopic findings of temporomandibular joint disorders

Kaneyama, K., Segami, N., Sato, J., Nishimura, M., & Yoshimura, H. (2003) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/s1079-2104(03)00374-3 · Cited by 9

Parathyroid Hormone and Parathyroid Hormone-Related Protein

Nissenson, R. A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00012-1 · Cited by 10

2,3,5,4′-tetrahydroxystilbene-2-O-β-D-glucoside–stimulated dental pulp stem cells-derived exosomes for wound healing and bone regeneration

Lin, T.-Y., Huang, T.-Y., Chiu, H., Chung, Y.-Y., Lin, W., Lin, H., & Lee, S. (2024) · Journal of Dental Sciences · doi:10.1016/j.jds.2024.09.010 · Cited by 8

Inhibitory effect of 1,25-dihydroxyvitamin D 3 on Porphyromonas gingivalis -induced inflammation and bone resorption in vivo

Li, Z., Cao, L., Wang, Y., Zhang, Z., Fan, M., & Xu, Q. (2016) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2016.08.029 · Cited by 8

Integrative Analysis Confirmed the Association between Osteoprotegerin and Osteoporosis

Tang, H., Zhu, X., Wu, L., Mo, X., Deng, F., & Lei, S. (2019) · Chinese Medical Sciences Journal · doi:10.24920/003466 · Cited by 8

Cathepsin K degrades osteoprotegerin to promote osteoclastogenesis in vitro

Kawai, R., Sugisaki, R., Miyamoto, Y., Yano, F., Sasa, K., Minami, E., Maki, K., & Kamijo, R. (2023) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-023-00747-5 · Cited by 8

Regulation of SFRP-1 Expression in the Rat Dental Follicle

Liu, D., Yao, S., & Wise, G. E. (2012) · Connective Tissue Research · doi:10.3109/03008207.2012.664204 · Cited by 8

Chinese Herbal Formula Huo-Luo-Xiao-Ling Dan Protects against Bone Damage in Adjuvant Arthritis by Modulating the Mediators of Bone Remodeling

Nanjundaiah, S. M., Lee, D. Y. W., Berman, B., & Moudgil, K. D. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/429606 · Cited by 8

Identification and Functional Analyses of Molecular Haplotypes of the Human Osteoprotegerin Gene Promoter

Hagedorn, C., Telgmann, R., Dördelmann, C., Schmitz, B., Hasenkamp, S., Cambien, F., Paul, M., Brand, E., & Brand‐Herrmann, S. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.193532 · Cited by 8

Effect of continuous compressive force on the expression of RANKL, OPG, and VEGF in osteocytes

YASHIMA, Y., Kaku, M., Yamamoto, T., Izumino, J., Kagawa, H., IKEDA, K., Shimoe, S., & Tanimoto, K. (2020) · Biomedical Research · doi:10.2220/biomedres.41.91 · Cited by 8

Common Variants of the OPG gene Are Associated with Osteoporosis Risk: A Meta-Analysis

Li, X., Cheng, J., Dong, B., Yu, X., Zhao, X., & Zhou, Z. (2021) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2020.0282 · Cited by 8

Negative autoregulation of RANKL and c-Src signaling in osteoclasts

Yogo, K., Ishida‐Kitagawa, N., & Takeya, T. (2007) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-007-0751-2 · Cited by 8

The Clinical Significance of OPG/sRANKL Ratio in Thalassemia Patients Suffering from Osteopenia or Osteoporosis in Egyptian Patients

Salah, H. E., Atfy, M., Fathy, A., Atfy, M., Mansor, H., & Saeed, J. (2010) · Immunological Investigations · doi:10.3109/08820139.2010.498492 · Cited by 7

Iontophoresis Significantly Increases the Trans-dentinal Delivery of Osteoprotegerin, Alendronate, and Calcitonin

Kitchens, J. A., Schwartz, S. A., Schindler, W. G., & Hargreaves, K. (2007) · Journal of Endodontics · doi:10.1016/j.joen.2007.06.017 · Cited by 8

A CD46 transgenic mouse model for studying the histopathology of arthritis caused by subcutaneous infection with Streptococcus dysgalactiae subspecies equisimilis

Yoshida, H., Matsui, H., Murayama, S. Y., Takada, Y., Matsuo, K., Takahashi, T., Nakamura, M., Ubukata, K., & Takahashi, T. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.034108-0 · Cited by 8

The Role of Inflammatory Cytokines and the RANKL-RANK-OPG Molecular Triad in Periodontal Bone Loss-A Review

Srinivasan, P. C. (2013) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.s13-007 · Cited by 9

The W9 peptide directly stimulates osteoblast differentiation via RANKL signaling

Nakamura, M., Nakamichi, Y., Mizoguchi, T., Koide, M., Yamashita, T., Ara, T., Nakamura, H., Penninger, J. M., Furuya, Y., Yasuda, H., et al. (2017) · Journal of Oral Biosciences · doi:10.1016/j.job.2017.05.001 · Cited by 8

Cervus and cucumis peptides ameliorates bone erosion in experimental arthritis by inhibiting osteoclastogenesis

Lin, Z., Liu, Y., Xu, Y., Yang, X., Zhu, F., Tang, W., He, S., & Zuo, J. (2019) · Lupus Science & Medicine · doi:10.1136/lupus-2019-000331 · Cited by 8

Assessment of the risk of incident heart failure in osteoporosis patients: a systematic review and meta-analysis of eligible cohort studies

Gu, Z.-J., Yuanyuan, Y., Lingyu, Z., & Chen, C. (2020) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.15598 · Cited by 8

La 1,25-dihydroxyvitamine D et son récepteur

Garabédian, M. (2000) · Revue du Rhumatisme · doi:10.1016/s1169-8330(00)80076-9 · Cited by 8

Rheumatoid Arthritis and other Inflammatory Joint Pathologies

Goldring, S. R., & Goldring, M. B. (2006) · Elsevier eBooks · doi:10.1016/b9-78-012088-5/62650-0522 · Cited by 8

Cytokines and Bone Remodeling

Mundy, G. R., Oyajobi, B. O., Traianedes, K., Dallas, S. L., & Chen, D. (2001) · Elsevier eBooks · doi:10.1016/b978-012470862-4/50014-3 · Cited by 8

Circulating osteoprotegerin in women during GnRH-agonist treatment and their relationships with mineral components and biomarkers of bone turnover

Uemura, H., Yasui, T., Umino, Y., Niki, H., Takikawa, M., Saito, S., Furumoto, H., & Irahara, M. (2003) · Bone · doi:10.1016/j.bone.2003.08.001 · Cited by 7

Bidirectional crosstalk between bone and muscle: the role of RANKL pathway in osteosarcopenia

Jang, S. Y., & Choi, K. M. (2024) · Journal of Endocrinology · doi:10.1530/joe-24-0093 · Cited by 9

Osteoprotegerin: regulator, protector and marker

Othmane, T., Speer, G., Fekete, B., Szabó, T., Egresits, J., Fodor, E., Kiss, I., Nemcsik, J., Szabó, A., Németh, Z., et al. (2008) · Orvosi Hetilap · doi:10.1556/oh.2008.28470 · Cited by 7

Elevated circulating osteoprotegerin and reduced matrix-metalloprotease-9 in post-menopausal women with chronic Hepatitis C virus infection

Nanda, K. S., Brady, J. J., Murray, B., Sullivan, O., Fearon, U., McKenna, M. J., Hegarty, J. E., O’Farrelly, C., & Ryan, E. J. (2012) · Cytokine · doi:10.1016/j.cyto.2012.07.006 · Cited by 7

Serum RANKL levels in Chinese patients with ankylosing spondylitis: a meta-analysis

Ni, F., Zhang, Y., Peng, Y., Peng, X., & Li, J. (2021) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-021-02721-x · Cited by 7

Developmental Pathways in CAVD

Elaine, E., & Katherine, E. (2013) · InTech eBooks · doi:10.5772/54356 · Cited by 8

PEGylation of osteoprotegerin/osteoclastogenesis inhibitory factor (OPG/OCIF) results in decreased uptake into rats and human liver

Saito-Yabe, M., Kasuya, Y., Yoshigae, Y., Yamamura, N., Suzuki, Y., Fukuda, N., Honma, M., Yano, K., Mochizuki, S.-I., Okada, F., et al. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01120.x · Cited by 7

Pharmacokinetics and disposition of recombinant human osteoprotegerin (rhOPG) after intravenous administration in female fischer rats

Miyaji, Y., Kurihara, A., Kamiyama, E., Shiiki, T., Kawai, K., & Okazaki, O. (2009) · Xenobiotica · doi:10.1080/00498250802590745 · Cited by 7

Using the ratio of serum osteoprotegerin ligand to osteoprotegerin to evaluate renal osteodystrophy in dialysis patients.

Grzegorzewska, A. E., & Młot-Michalska, M. (2005) · PubMed · Cited by 7

A novel molecular mechanism modulating osteoclast differentiation and function

Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Goto, M., Mochizuki, S.-I., Tsuda, E., Morinaga, T., Udagawa, N., et al. (1999) · Bone · doi:10.1016/s8756-3282(99)00121-0 · Cited by 264

Osteoclast Differentiation Factor is a Ligand for Osteoprotegerin / Osteoclastogenesis-Inhibitory Factor

Shima, N., Yasuda, H., Nakagawa, N., Yamaguchi, K., Tsuda, E., Morinaga, T., Suda, T., & Higashio, K. (2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46869-7_43 · Cited by 1

Recent Advance in Osteoclastogenesis Inhibitory Factor.

Zhi, H. (2000) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS

16. Lack of antagonist activity of melanocyte-stimulating hormone (MSH) on the actions of IL-1 on human bone-derived osteoblast-like cells

Evans, D., Thavarajah, M., & Kanis, J. A. (1991) · Bone · doi:10.1016/8756-3282(91)90112-v

Transforming Growth Factor-β Stimulates the Production of Osteoprotegerin/Osteoclastogenesis Inhibitory Factor by Bone Marrow Stromal Cells

Takai, H., Kanematsu, M., Yano, K., Tsuda, E., Higashio, K., Ikeda, K., Watanabe, K., & Yamada, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27091 · Cited by 299